Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN).
Maurizio Averna, Angelo B Cefalù, Manuela Casula...
https://pubmed.ncbi.nlm.nih.gov/28965615Actively Recruiting
All Genders
ID06362473
Lipid Transport Disorder Italian Genetic Record (LIPIGEN) Observational Study for Familial Hypercholesterolemia and Genetic Dyslipidemias
Led by Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) · Updated on 2024-04-12
10000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting the LIPIGEN observational study to better understand diseases related to blood lipid levels, such as familial hypercholesterolaemia (FH) and other genetic dyslipidaemias. The study involves Italian physicians and researchers who aim to improve diagnosis and treatment by collecting detailed patient information and analyzing genetic causes. This research may help identify the most effective treatments and monitor long-term health outcomes. Participants continue their usual clinical care while the study collects data from their medical records, family history, and genetic testing without adding extra procedures. In some cases, additional evaluations like ultrasounds may be performed to better assess the condition. The study involves more than 50 centers across Italy, making it accessible to many individuals with these conditions. Throughout the study, researchers will evaluate patients' lipid and genetic profiles at baseline and observe treatment adherence, cardiovascular events, and other important health outcomes over time. Participants' involvement includes regular clinical visits and data collection as part of standard care. The study began in 2015 and will continue through 2026, aiming to enhance personalized diagnosis and treatment strategies for genetic lipid disorders.
CONDITIONS
Brief Title
Lipid Transport Disorder Italian Genetic Record (LIPIGEN)
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
- Molecular or clinical diagnosis of genetic dyslipidemia
- Signed informed consent
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Diagnostic Evaluation
Duration - Baseline evaluation
Participants undergo evaluations to assess their lipid and genetic profiles.
1 visit (in-person)
Long-term Monitoring
Duration - Ongoing until study completion
Participants are observed to collect data related to lipid-lowering treatments and genetic dyslipidemias.
Trial Site Locations
Total: 1 location
1
IRCCS Multimedica
Sesto San Giovanni, Milano, Italy, 20099
Actively Recruiting
Loading map...
Research Team
M
Manuela Casula, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here